Citigroup
PRCT icon

Citigroup’s Procept Biorobotics PRCT Stock Holding History

Citigroup’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.38M Buy
415,438
+92,693
+29% +$2.32M ﹤0.01% 1668
2026
Q1 		$8.07M Buy
322,745
+178,144
+123% +$5.02M ﹤0.01% 1604
2025
Q4 		$4.55M Buy
144,601
+15,716
+12% +$521K ﹤0.01% 2080
2025
Q3 		$4.6M Buy
128,885
+45,979
+55% +$2.1M ﹤0.01% 2025
2025
Q2 		$4.78M Sell
82,906
-20,000
-19% -$1.13M ﹤0.01% 1928
2025
Q1 		$6M Buy
102,906
+60,009
+140% +$4.1M ﹤0.01% 1744
2024
Q4 		$3.45M Buy
42,897
+6,821
+19% +$583K ﹤0.01% 2324
2024
Q3 		$2.89M Buy
36,076
+22,483
+165% +$1.6M ﹤0.01% 2343
2024
Q2 		$830K Buy
13,593
+2,750
+25% +$164K ﹤0.01% 3042
2024
Q1 		$536K Buy
10,843
+972
+10% +$46.3K ﹤0.01% 3519
2023
Q4 		$414K Buy
9,871
+3,954
+67% +$135K ﹤0.01% 3543
2023
Q3 		$194K Sell
5,917
-14,773
-71% -$504K ﹤0.01% 3670
2023
Q2 		$731K Buy
20,690
+13,793
+200% +$456K ﹤0.01% 3080
2023
Q1 		$196K Buy
6,897
+1,644
+31% +$58K ﹤0.01% 3750
2022
Q4 		$218K Sell
5,253
-1,533
-23% -$65.8K ﹤0.01% 3672
2022
Q3 		$281K Buy
6,786
+3,500
+107% +$140K ﹤0.01% 3595
2022
Q2 		$107K Buy
3,286
+2,929
+820% +$107K ﹤0.01% 4191
2022
Q1 		$12K Sell
357
-1,563
-81% -$37.6K ﹤0.01% 5438
2021
Q4 		$48K Buy
+1,920
New +$71K ﹤0.01% 5085

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Citigroup's PRCT Position: Q2 2026 in Review

Citigroup increased its Procept Biorobotics (PRCT) stake by 29% in Q2 2026, buying an estimated $2.32M and bringing the position to 415,438 shares worth $9.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1668.

Citigroup first reported a position in PRCT in Q4 2021 and has held it in 19 quarters since. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Citigroup held 415,438 shares of Procept Biorobotics worth $9.38M as of Q2 2026.
  • Citigroup bought 92,693 Procept Biorobotics shares in Q2 2026, an estimated $2.32M.
  • Procept Biorobotics made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #1668 holding.
  • Citigroup first reported a position in Procept Biorobotics in Q4 2021 and has held it in 19 quarters since.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.